Health Industry· KFF Health News

People Say These Peptides Hurt Them. Their Stories Are Muffled in MAHA’s Push for Medical Freedom.

By Amy Maxmen, KFF Health News · October 13, 2026

People who have taken experimental peptides, such as BPC-157, complain of migraines, eye pain, fatigue, and more. Learning whether these popular but unproven drugs are to blame may become harder if Robert F. Kennedy Jr. fulfills a promise to make them more accessible.

Continue readingRead the full story at KFF Health News

People Say These Peptides Hurt Them. Their Stories Are Muffled in MAHA’s Push for Medical Freedom.

More in Health Industry

Fed Up With the Healthcare Industry, This Red State Capped Insulin Prices for Patients

Nebraska Rushed Medicaid Work Rules. Then a Cancer Patient Was Told He’d Lost Coverage.

Midterm Wave Sets a Course for ‘Medicare for All’ Fight